Inovio Pharmaceuticals (INO) Insider Trading & Ownership $1.97 -0.05 (-2.48%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$1.97 0.00 (0.00%) As of 05/23/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Inovio Pharmaceuticals (NASDAQ:INO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.30%Number OfInsiders Buying(Last 3 Years)0Number OfInsiders Selling(Last 3 Years)2Amount OfInsider Selling(Last 3 Years)$57,175.20 Get INO Insider Trade Alerts Want to know when executives and insiders are buying or selling Inovio Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address INO Insider Buying and Selling by Quarter Inovio Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/13/2023David B WeinerDirectorSell40$165.60$6,624.00 2/27/2023David B WeinerDirectorSell81$184.32$14,929.92 8/11/2022David B WeinerDirectorSell82$383.04$31,409.28 7/20/2022Simon X BenitoDirectorSell13$324.00$4,212.00 (Data available from 1/1/2013 forward) INO Insider Trading Activity - Frequently Asked Questions Who is on Inovio Pharmaceuticals's Insider Roster? The list of insiders at Inovio Pharmaceuticals includes David B Weiner, and Simon X Benito. Learn more on insiders at INO. What percentage of Inovio Pharmaceuticals stock is owned by insiders? 2.30% of Inovio Pharmaceuticals stock is owned by insiders. Learn more on INO's insider holdings. Inovio Pharmaceuticals Key ExecutivesDr. Jacqueline E. Shea Ph.D. (Age 58)CEO, President & Director Compensation: $1.13MMr. Peter D. Kies (Age 61)Chief Financial Officer Compensation: $810.2kDr. Laurent M. Humeau Ph.D. (Age 57)Chief Scientific Officer & Chairman of the Scientific Advisory Board Compensation: $794.08kThomas HongManager of Investor RelationsMr. Robert L. Crotty J.D. (Age 50)General Counsel & Chief Compliance Officer Mr. E. J. Brandreth MBASenior Vice President of Quality AssuranceDr. Jeffrey SkolnikSenior Vice President of Clinical DevelopmentMr. Robert J. Juba Jr.Senior Vice President of Biological Manufacturing & Clinical Supply ManagementMr. Stephen Kemmerrer M.B.A.P.E., Senior Vice President of Engineering DevelopmentMr. Shawn D. Bridy M.A.M.B.A., Senior Vice President of Business Development More Insider Trading Tools from MarketBeat Related Companies STIM Insider Transactions SMTI Insider Transactions SNWV Insider Transactions ZIMV Insider Transactions TCMD Insider Transactions NVRO Insider Transactions SKIN Insider Transactions CATX Insider Transactions LAKE Insider Transactions ELMD Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Turbulence for Joby Shares: What's Behind the Recent Dip?UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?Sprouts Stock: Insider Sales, But Strong Bullish Signals5 Hot Small-Cap Insiders Bought at the Peak of Tariff FearsThe Top-Ranked Insider Buys From April by Market Cap This page (NASDAQ:INO) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inovio Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inovio Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy INO Stock Free INO Stock Alerts